Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

314 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris.
Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Williams Z, Peyri Rey J, Svensson A, Toole J, Wozel G. Kragballe K, et al. Among authors: cambazard f. Dermatology. 2006;213(4):319-26. doi: 10.1159/000096069. Dermatology. 2006. PMID: 17135738 Clinical Trial.
Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial.
White S, Vender R, Thaçi D, Haverkamp C, Naeyaert JM, Foster R, Martinez Escribano JA, Cambazard F, Bibby A. White S, et al. Among authors: cambazard f. Am J Clin Dermatol. 2006;7(3):177-84. doi: 10.2165/00128071-200607030-00004. Am J Clin Dermatol. 2006. PMID: 16734505 Clinical Trial.
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Jolliffe D, Peyri J, Svensson A, Toole J, Wozel G. Kragballe K, et al. Among authors: cambazard f. Br J Dermatol. 2006 Jun;154(6):1155-60. doi: 10.1111/j.1365-2133.2006.07236.x. Br J Dermatol. 2006. PMID: 16704648 Clinical Trial.
A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris.
Zouboulis CC, Derumeaux L, Decroix J, Maciejewska-Udziela B, Cambazard F, Stuhlert A. Zouboulis CC, et al. Among authors: cambazard f. Br J Dermatol. 2000 Sep;143(3):498-505. doi: 10.1111/j.1365-2133.2000.03701.x. Br J Dermatol. 2000. PMID: 10971320 Clinical Trial.
314 results